• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

PX’Therapeutics (Group)

PX'Therapeutics is a biopharmaceutical contract research and manufacturing organisation specialising in the development of therapeutic antibodies and recombinant proteins from early research stage up to clinical grade GMP manufacturing. With more than 160 clients in Europe, North America and Japan, PX'Therapeutics has acquired an extensive knowledge in the production of valuable therapeutic candidates. *

 

	Start	2008-09-29 renamed
	Industry	PSAQ™ method (Protein Standard for Absolute Quantification)
	Region	Grenoble
	Country	France
	Street	7 Parvis Louis Néel
	City	38040 Grenoble cedex 9
	Tel	+33-438-023-650
	Fax	+33-476-961-038
		Address record changed: 2011-12-28
Basic data	Employees	n. a.
		* Document for »About Section«: PX’Therapeutics S.A.. (9/6/11). "Press Release: PX’Therapeutics Licenses Ribovax’s SEBVI Technology for the Development and Manufacturing of Fully Human Monoclonal Antibodies".
		Record changed: 2011-12-28

More documents for PX’Therapeutics (Group)

• [1] Promise Advanced Proteomics. (9/14/10). "Corporate Information by E-Mail"....
• [2] –. (9/10/10). "News: New French Proteomics Firm Launches". New York....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.